Official SEC submissions

Telomir Pharmaceuticals SEC Filings

Telomir Pharmaceuticals (TELO) SEC filings, periodic reports and insider submis…

Direct answer

Telomir Pharmaceuticals's latest SEC filing is DEFA14A.

It was filed on August 19, 2026, and 40 recent filings are available.

Each row links directly to the SEC document and filing index.

Official SEC EDGAR submissions

Get free Telomir Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

DEFA14A

Proxy statement

Filed: 2026-08-19

DEFA14A

Open SEC document View filing index

10-Q

Periodic report

Filed: 2026-08-13

Report date: 2026-06-30

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2026-08-10

Report date: 2026-08-10

8-K

Open SEC document View filing index

DEF 14A

Proxy statement

Filed: 2026-07-28

Report date: 2026-07-28

DEF 14A

Open SEC document View filing index

Insider transaction

Filed: 2026-07-27

Report date: 2026-04-16

Open SEC document View filing index

Insider transaction

Filed: 2026-07-27

Report date: 2026-04-16

Open SEC document View filing index

Insider transaction

Filed: 2026-07-27

Report date: 2026-04-16

Open SEC document View filing index

8-K

Current report

Filed: 2026-06-15

Report date: 2026-06-15

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-06-08

Report date: 2026-06-03

8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-05-22

Report date: 2026-05-21

Open SEC document View filing index

Insider transaction

Filed: 2026-05-22

Report date: 2026-05-21

Open SEC document View filing index

Insider transaction

Filed: 2026-05-22

Report date: 2026-05-21

Open SEC document View filing index

Insider transaction

Filed: 2026-05-22

Report date: 2026-05-21

Open SEC document View filing index

8-K

Current report

Filed: 2026-05-20

Report date: 2026-05-20

8-K

Open SEC document View filing index

10-Q

Periodic report

Filed: 2026-05-14

Report date: 2026-03-31

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2026-04-30

Report date: 2026-04-24

8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-04-24

Report date: 2026-04-22

Open SEC document View filing index

8-K

Current report

Filed: 2026-04-24

Report date: 2026-04-22

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-03-31

Report date: 2026-03-30

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-03-31

Report date: 2026-03-31

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-03-27

Report date: 2026-03-23

8-K

Open SEC document View filing index

10-K

Periodic report

Filed: 2026-03-17

Report date: 2025-12-31

10-K

Open SEC document View filing index

DEFA14A

Proxy statement

Filed: 2026-02-19

DEFA14A

Open SEC document View filing index

8-K

Current report

Filed: 2026-02-17

Report date: 2026-02-17

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-02-05

Report date: 2026-02-05

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-01-12

Report date: 2026-01-08

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-01-05

Report date: 2026-01-05

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-12-22

Report date: 2025-12-17

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-12-17

Report date: 2025-12-17

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-11-24

Report date: 2025-11-24

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-11-20

Report date: 2025-11-14

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-11-20

Report date: 2025-11-20

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-11-12

Report date: 2025-11-12

8-K

Open SEC document View filing index

10-Q

Periodic report

Filed: 2025-11-10

Report date: 2025-09-30

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2025-10-22

Report date: 2025-10-22

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-10-20

Report date: 2025-10-17

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-10-14

Report date: 2025-10-14

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-10-08

Report date: 2025-10-08

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-10-06

Report date: 2025-10-06

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-09-18

Report date: 2025-09-18

8-K

Open SEC document View filing index

Verified data

Recent filing categories: 4
Recent filings: 40
SEC CIK: 0001971532
Latest filing date: August 19, 2026

Explore related company data

View the Telomir Pharmaceuticals company profile View Telomir Pharmaceuticals annual financials